Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)

SHA:688639 Revenue

Anhui Huaheng Biotechnology had revenue of 743.77M CNY in the quarter ending September 30, 2026, with 5.59% growth. This brings the company's total for the last twelve months to 3.04B, up 7.48% year-over-year. In the year 2025, Anhui Huaheng Biotechnology had annual revenue of 2.86B with 31.40% growth. That makes Anhui Huaheng Biotechnology the 11,779th largest company in the world by revenue and 2,007th in China.

• Revenue (ttm): 3.04B
• Revenue Growth: +7.48%
• P/S Ratio: 1.44
• Revenue / Employee: 1.35M
• Employees: 2,252
• Market Cap: 4.37B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• China 1.18B 51.2%
• Overseas 1.13B 48.8%

Fiscal year ended Dec 31, 2025 See the full SHA:688639 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.86B	683.90M	31.40%
Dec 31, 2024	2.18B	239.67M	12.37%
Dec 31, 2023	1.94B	519.62M	36.63%
Dec 31, 2022	1.42B	464.56M	48.69%
Dec 31, 2021	954.10M	466.85M	95.81%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error